GM Advisory Group’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Sell |
4,015
-7,113
| -64% | -$2.12M | 0.04% | 161 |
|
|
2025
Q4 | $3.67M | Sell |
11,128
-4,725
| -30% | -$1.6M | 0.14% | 76 |
|
|
2025
Q3 | $5.47M | Sell |
15,853
-1,656
| -9% | -$501K | 0.23% | 56 |
|
|
2025
Q2 | $5.46M | Buy |
17,509
+10,829
| +162% | +$4.14M | 0.27% | 53 |
|
|
2025
Q1 | $3.5M | Sell |
6,680
-1,311
| -16% | -$670K | 0.19% | 62 |
|
|
2024
Q4 | $4.04M | Sell |
7,991
-1,078
| -12% | -$613K | 0.22% | 56 |
|
|
2024
Q3 | $5.3M | Sell |
9,069
-293
| -3% | -$166K | 0.32% | 50 |
|
|
2024
Q2 | $4.77M | Sell |
9,362
-3,247
| -26% | -$1.59M | 0.31% | 53 |
|
|
2024
Q1 | $6.24M | Buy |
12,609
+2,172
| +21% | +$1.1M | 0.44% | 41 |
|
|
2023
Q4 | $5.49M | Sell |
10,437
-54
| -0.5% | -$28.8K | 0.42% | 39 |
|
|
2023
Q3 | $5.29M | Sell |
10,491
-5
| -0% | -$2.46K | 0.43% | 35 |
|
|
2023
Q2 | $5.04M | Sell |
10,496
-584
| -5% | -$286K | 0.42% | 34 |
|
|
2023
Q1 | $5.24M | Buy |
11,080
+1,306
| +13% | +$630K | 0.48% | 32 |
|
|
2022
Q4 | $5.18M | Buy |
9,774
+5
| +0.1% | +$2.65K | 0.55% | 27 |
|
|
2022
Q3 | $4.93M | Sell |
9,769
-163
| -2% | -$85.7K | 0.62% | 22 |
|
|
2022
Q2 | $5.1M | Buy |
9,932
+4,605
| +86% | +$2.31M | 0.8% | 23 |
|
|
2022
Q1 | $2.72M | Sell |
5,327
-91
| -2% | -$43.9K | 0.32% | 50 |
|
|
2021
Q4 | $2.72M | Buy |
5,418
+7
| +0.1% | +$3.17K | 0.24% | 58 |
|
|
2021
Q3 | $2.11M | Buy |
5,411
+39
| +0.7% | +$16.2K | 0.21% | 58 |
|
|
2021
Q2 | $2.15M | Sell |
5,372
-277
| -5% | -$110K | 0.22% | 62 |
|
|
2021
Q1 | $2.1M | Sell |
5,649
-74
| -1% | -$25.6K | 0.25% | 55 |
|
|
2020
Q4 | $2.01M | Buy |
5,723
+56
| +1% | +$18.8K | 0.27% | 48 |
|
|
2020
Q3 | $1.77M | Sell |
5,667
-45
| -0.8% | -$13.8K | 0.27% | 45 |
|
|
2020
Q2 | $1.69M | Buy |
5,712
+45
| +0.8% | +$12.9K | 0.31% | 48 |
|
|
2020
Q1 | $1.41M | Buy |
5,667
+2,327
| +70% | +$640K | 0.38% | 39 |
|
|
2019
Q4 | $982K | Sell |
3,340
-354
| -10% | -$92.6K | 0.3% | 33 |
|
|
2019
Q3 | $803K | Buy |
3,694
+434
| +13% | +$105K | 0.25% | 42 |
|
|
2019
Q2 | $795K | Sell |
3,260
-179
| -5% | -$43.1K | 0.25% | 47 |
|
|
2019
Q1 | $850K | Hold |
3,439
| – | – | 0.28% | 44 |
|
|
2018
Q4 | $857K | Hold |
3,439
| – | – | 0.32% | 41 |
|
|
2018
Q3 | $915K | Hold |
3,439
| – | – | 0.29% | 51 |
|
|
2018
Q2 | $844K | Hold |
3,439
| – | – | 0.25% | 49 |
|
|
2018
Q1 | $736K | Sell |
3,439
-12
| -0.3% | -$2.74K | 0.22% | 52 |
|
|
2017
Q4 | $761K | Buy |
3,451
+1,539
| +80% | +$326K | 0.21% | 54 |
|
|
2017
Q3 | $374K | Hold |
1,912
| – | – | 0.11% | 75 |
|
|
2017
Q2 | $355K | Sell |
1,912
-424
| -18% | -$74.3K | 0.11% | 80 |
|
|
2017
Q1 | $383K | Hold |
2,336
| – | – | 0.13% | 70 |
|
|
2016
Q4 | $374K | Buy |
+2,336
| New | +$349K | 0.13% | 76 |
|
|
2014
Q2 | – | Sell |
-3,860
| Closed | -$314K | – | 82 |
|
|
2014
Q1 | $314K | Hold |
3,860
| – | – | 0.24% | 44 |
|
|
2013
Q4 | $291K | Buy |
+3,860
| New | +$277K | 0.3% | 42 |
|
Other funds holding UNH
VCM
VPM
GM Advisory Group's UNH Position: Q1 2026 in Review
GM Advisory Group reduced its UnitedHealth (UNH) stake by 64% in Q1 2026, selling an estimated $2.12M and leaving 4,015 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #161.
GM Advisory Group first reported a position in UNH in Q4 2013 and has held it in 40 quarters since. The position peaked at $6.24M in Q1 2024. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- GM Advisory Group held 4,015 shares of UnitedHealth worth $1.09M as of Q1 2026.
- GM Advisory Group sold 7,113 UnitedHealth shares in Q1 2026, an estimated $2.12M.
- UnitedHealth made up 0.04% of GM Advisory Group's portfolio in Q1 2026, its #161 holding.
- GM Advisory Group first reported a position in UnitedHealth in Q4 2013 and has held it in 40 quarters since.
- GM Advisory Group's UnitedHealth position peaked at $6.24M in Q1 2024.
- 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.